Americann, INC
Market Movers (8-K)
OTC.Pink
ACAN
Americann, INCAmeriCann Inc. has transferred development rights for a portion of its Freetown, Massachusetts property to Massachusetts Medical Properties, LLC, receiving a $650,000 deposit and a potential 20% share of future sales.
OTC.Pink
ACAN
Americann, INCAmericann, Inc. reports the resignation of director J. Tyler Opel, effective August 23, 2024.
OTC.Pink
ACAN
Americann, INCAmericann, Inc. reported the resignation of director J. Tyler Opel, effective August 23, 2024.
OTC.Pink
ACAN
Americann, INCAmeriCann, Inc. will terminate its lease with BASK, Inc. for a Massachusetts cannabis facility and transition to operating the facility directly, acquiring licenses and equipment in the process.
Better than expected
Quarterly Earnings (10-Q)
OTC.Pink
ACAN
Americann, INCAmeriCann, Inc. reports a net loss for Q1 2025, primarily due to a lease termination and changes in its operational structure.
Capital raise
Worse than expected
OTC.Pink
ACAN
Americann, INCAmeriCann Inc. experienced a decrease in revenue and a net loss for the third quarter of 2024, primarily due to a lease modification and the upcoming termination of a key lease agreement.
Worse than expected
Capital raise
OTC.Pink
ACAN
Americann, INCAmeriCann, Inc. reported a net loss for the second quarter of 2024, with a decrease in revenue primarily due to reduced tenant sales, and announced the termination of a key lease agreement.
Worse than expected
Delay expected
Capital raise
OTC.Pink
ACAN
Americann, INCAmeriCann Inc. experienced a decrease in revenue and a net loss for the quarter ended December 31, 2023, primarily due to pricing pressures in the Massachusetts cannabis market.
Worse than expected
Delay expected
Capital raise
Annual Reports (10-K)
OTC.Pink
ACAN
Americann, INCAmeriCann Inc.'s FY2024 report reveals a net loss, lease modifications, and ongoing efforts to navigate the complex cannabis industry landscape.
Worse than expected
Insider Trading (Form 4)
OTC.Pink
ACAN
Americann, INCStrategic Capital Partners, LLC, a 10% owner of AmeriCann, Inc., reports the disposal of 8,966,665 common stock shares on March 21, 2025.